Pigmentation Disorder Treatment Market Predicted to Reach $1.22 Billion by 2031, Says Allied Market Research

Rise in awareness about pigmentaion disorders drives the growth of the global pigmentation disorder treatment market. Based on treatment, the corticosteroids segment held the major share in 2021. By region, however, Asia-Pacific would cite the fastest CAGR by 2031.

Portland, OR, Nov. 11, 2022 (GLOBE NEWSWIRE) — According to the report published by Allied Market Research, the global pigmentation disorder treatment market was estimated at $799.8 million in 2021 and is expected to hit $1.22 billion by 2031, registering a CAGR of 4.3% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

Download Free Sample Report- https://www.alliedmarketresearch.com/request-sample/11594

Report coverage & details:

Report Coverage Details
Forecast Period 2022–2031
Base Year 2021
Market Size in 2021 $799.8 Million
Market Size in 2031 $1.22 Billion
CAGR 4.3%
No. of Pages in Report 275
Segments Covered Type, Treatment, Distribution Channel, and Region.
Drivers Rise in awareness about pigmentaion disorders
Restraints High cost of treatments
Opportunities Development in the healthcare sector in the developed and developing economies

Covid-19 scenario-

  • The outbreak of the pandemic had a negative impact on the growth of the global pigmentation disorder treatment market.  Manufacturing, logistical, and transportation operations were disrupted during the lockout, which hampered the market expansion.
  • However, the market has recovered aloly and steadily.

The global pigmentation disorder treatment market is analyzed across procedure type, treatment, distribution channel, and region. The report takes in an exhaustive analysis of segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.

By type, the vitiligo segment contributed to more than half of the global pigmentation disorder treatment market in 2021, and is expected to dominate by 2031. The same segment would also showcase the fastest CAGR of 4.6% throughout the forecast period.

Based on treatment, the corticosteroids segment held more than two-thirds of the total market revenue in 2021, and is expected to dominate by 2031. The same segment would also manifest the fastest CAGR of 4.4% throughout the forecast period.

Based on distribution channel, the drug store and retail pharmacies segment held more than three-fifths of the total market revenue in 2021, and is expected to dominate by 2031. The online pharmacies segment, however, would cite the fastest CAGR of 6.3% throughout the forecast period.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/11594

Based on region, the market across North America generated more than two-fifths of the global market revenue in 2021, and is anticipated to retain the lion’s share by 2031. The Asia-Pacific region, at the same time, would manifest the fastest CAGR of 5.1% during the forecast period. The other provinces analyzed in the report include Europe and LAMEA.

The key market players analyzed in the global pigmentation disorder treatment market report include Astellas Pharma Inc., Bausch Health Companies Inc, Arcutis Biotherapeutics, Incyte Corporation, Dermavant Science Inc., Galderma SA, Obagi Cosmeceuticals LLC, Dr. Reddy’s, and Viatirs Inc. (Mylan N.V.), Laboratories Limited, and Glenmark Pharmaceuticals Ltd. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry. The report is helpful in formulating the business performance, product portfolio, operating segments, and developments by the top players. 

Trending Reports in Healthcare Industry-

Medical Videoscope Market- Global Opportunity Analysis and Industry Forecast, 2020-2030

Patient Monitoring Devices Market – Global Opportunity Analysis and Industry Forecast, 2020–2030

Micromanipulators Market- Global Opportunity Analysis and Industry Forecast, 2020–2030

Flow Cytometry Market- Global Opportunity Analysis and Industry Forecast, 2020–2030

Postpartum Hemorrhage (PPH) Devices Market- Wearable Injectors Market – Global Opportunity Analysis and Industry Forecast, 2020–2030

Extremity Reconstruction Market – Global Opportunity Analysis and Industry Forecast, 2020–2030

Automated Radiosynthesis Modules Market – Global Opportunity Analysis and Industry Forecast, 2020–2030

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220                                                               
United States
Toll Free: +1-800-792-5285                                                             
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected] 
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn Twitter

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Mango Bunch takes no editorial responsibility for the same.